The routine therapeutic drugs for osteoporosis include BPs, selective estrogen receptor modulators, and parathyroid hormone analogs, matched to the intervention of osteoporosis under different etiologies, fulfilling ideal efficacy while accompanied by certain adverse effects (33). This evidence concerns the gene PTH and osteoporosis.